Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 192.55bn | 194.63bn | 213.03bn | 248.89bn | 164.20bn | 109.08bn | 163.53bn |
| Research and development | 274m | 301m | 298m | 274m | 266m | 332m | 364m |
| Operating income | 12.64bn | 11.30bn | 27.35bn | 18.04bn | 18.08bn | −21.74bn | 11.71bn |
| Pre-tax income | 7.75bn | 6.78bn | 23.75bn | 15.41bn | 15.23bn | −24.89bn | 8.15bn |
| Income tax | 6.45bn | 5.55bn | 7.87bn | 16.76bn | 6.74bn | −4.16bn | 3.96bn |
| Net income | 1.30bn | 1.23bn | 15.88bn | −1.36bn | 8.49bn | −20.73bn | 4.19bn |
| Metric | Aug 18, 2026 | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | 36.56bn | 39.20bn | 33.03bn | 29.20bn | 30.68bn | 31.11bn | 22.47bn |
| Receivables | — | 21.11bn |
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 24.49bn | 27.30bn | 32.04bn | 40.93bn | 23.61bn | 12.16bn | 25.77bn |
| Depreciation and amortisation | 17.82bn | 16.62bn | 15.93bn |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 21.66bn |
| 25.18bn |
| 28.23bn |
| 22.31bn |
| 12.93bn |
| 19.42bn |
| Inventory | — | 22.50bn | 23.23bn | 22.82bn | 28.08bn | 23.71bn | 16.87bn | 20.88bn |
| Current assets | — | 101.79bn | 102.83bn | 104.15bn | 107.69bn | 92.59bn | 72.98bn | 82.06bn |
| Property, plant and equipment | — | 98.63bn | 100.24bn | 104.72bn | 106.04bn | 112.90bn | 114.84bn | 132.64bn |
| Goodwill | — | 10.30bn | 14.89bn | 12.47bn | 11.96bn | 12.37bn | 12.48bn | 11.87bn |
| Total assets | — | 278.53bn | 282.23bn | 280.29bn | 288.12bn | 287.27bn | 267.65bn | 295.19bn |
| Current liabilities | — | 80.58bn | 82.24bn | 86.08bn | 99.02bn | 80.29bn | 59.80bn | 73.60bn |
| Short-term debt | — | 3.36bn | 4.47bn | 3.28bn | 3.20bn | 5.56bn | 9.36bn | 10.49bn |
| Long-term debt | — | 54.60bn | 55.07bn | 48.67bn | 43.75bn | 55.62bn | 63.31bn | 57.24bn |
| Total liabilities | — | 204.53bn | 203.91bn | 194.80bn | 205.13bn | 196.83bn | 182.09bn | 194.49bn |
| Equity | — | 74.00bn | 78.32bn | 85.49bn | 82.99bn | 90.44bn | 85.57bn | 100.71bn |
| 14.32bn |
| 14.81bn |
| 14.89bn |
| 17.78bn |
| Share-based compensation | 1.08bn | 1.17bn | 616m | 795m | 627m | 723m | 730m |
| Investing cash flow | −11.50bn | −13.25bn | −14.87bn | −13.71bn | −5.69bn | −7.86bn | −16.97bn |
| Financing cash flow | −15.88bn | −7.30bn | −13.36bn | −28.02bn | −18.08bn | 3.96bn | −8.82bn |